CVS, Aetna executives defend $69 billion deal with eye on savings

NEW YORK (Reuters) - CVS Health Corp and Aetna Inc top executives on Monday defended their planned merger to Wall Street analysts who questioned the $69 billion deal, promising both near- and long-term savings for the combined company.

NEW YORK (Reuters) - CVS Health Corp and Aetna Inc top executives on Monday defended their planned merger to Wall Street analysts who questioned the $69 billion deal, promising both near- and long-term savings for the combined company.